Related Experiment Video
Updated: May 14, 2026
09:16
Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Array-CGH analysis of cutaneous anaplastic large cell lymphoma
K Szuhai1, R van Doorn, C P Tensen
1Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
Methods in Molecular Biology (Clifton, N.J.)
|February 16, 2013
Summary
This study identified key chromosomal changes in cutaneous anaplastic large cell lymphoma (C-ALCL) using array-based comparative genomic hybridization. These findings differentiate C-ALCL from other cutaneous T-cell lymphomas and suggest new therapeutic targets.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Cutaneous anaplastic large cell lymphoma (C-ALCL) is a subtype of cutaneous T-cell lymphoma.
- Understanding the genetic basis of C-ALCL is crucial for developing targeted therapies.
- Previous studies have not fully elucidated the chromosomal alteration patterns in C-ALCL.
Purpose of the Study:
- To define the pattern of numerical chromosomal alterations in C-ALCL tumor samples.
- To identify recurrent chromosomal gains and losses specific to C-ALCL.
- To compare the chromosomal alterations in C-ALCL with those in other cutaneous T-cell lymphomas.
Main Methods:
- Array-based comparative genomic hybridization (CGH) was employed to analyze C-ALCL tumor specimens.
- The study details the array-based CGH technique for precise genomic profiling.
- Tumor samples from C-ALCL patients were subjected to detailed genomic analysis.
Main Results:
- Recurrent chromosomal alterations were identified in C-ALCL, including gain of 7q31 and losses on 6q16-6q21 and 13q34.
- These specific alterations were observed in 45% of the analyzed C-ALCL patients.
- The chromosomal alteration pattern in C-ALCL is distinct from mycosis fungoides and Sézary syndrome.
Conclusions:
- The study successfully characterized the genomic landscape of C-ALCL.
- Identified chromosomal alterations provide insights into C-ALCL pathogenesis.
- The distinct genetic profile of C-ALCL suggests unique therapeutic strategies may be required.
